
Sign up to save your podcasts
Or


This session from WHAV 2025 explores the complex interplay between hormonal changes and migraine pathophysiology in women, from menarche through menopause. Faculty review diagnostic frameworks, including ICHD-3 criteria, and emphasize menstrual migraine subtypes and the role of estrogen withdrawal. Evidence-based strategies for acute and preventive treatment are discussed, including the use of CGRP receptor antagonists, hormonal therapies, and neuromodulation devices. The program also addresses disparities in care and supports shared decision-making tailored to life stage, comorbidities, and patient preferences.
=
By ReachMD4.3
33 ratings
This session from WHAV 2025 explores the complex interplay between hormonal changes and migraine pathophysiology in women, from menarche through menopause. Faculty review diagnostic frameworks, including ICHD-3 criteria, and emphasize menstrual migraine subtypes and the role of estrogen withdrawal. Evidence-based strategies for acute and preventive treatment are discussed, including the use of CGRP receptor antagonists, hormonal therapies, and neuromodulation devices. The program also addresses disparities in care and supports shared decision-making tailored to life stage, comorbidities, and patient preferences.
=